(E)-N-methyl-2-(pyridin-2-ylmethylene)hydrazinecarbothioamide | 6839-88-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: (E)-N-methyl-2-(pyridin-2-ylmethylene)hydrazinecarbothioamide
• 英文别名: pyridine-2-carbaldehyde 4-N-methyl thiosemicarbazone；pyridine-2-carbaldehyde-(4-methyl thiosemicarbazone)；Pyridin-2-carbaldehyd-(4-methyl-thiosemicarbazon)；2-Formylpyridine 4-methyl-3-thiosemicarbazone；2-Formylpyridin-4'-methylthiosemicarbazon；3-Methyl-1-(pyridin-2-ylmethylideneamino)thiourea；1-methyl-3-[(E)-pyridin-2-ylmethylideneamino]thiourea
• CAS: 6839-88-9
• 化学式: C₈H₁₀N₄S
• mdl: MFCD24388269
• 分子量: 194.26
• InChiKey: PIQCUQKVCKNFCL-IZZDOVSWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  81.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (E)-N-methyl-2-(pyridin-2-ylmethylene)hydrazinecarbothioamide 在 potassium bromate 、 硫酸 作用下， 以 水 为溶剂， 生成 2-methylamino-5-pyridin-2-yl-1,3,4-oxadiazole
  参考文献：
  名称：

  新的 1,3,4-恶二唑铜 (II) 衍生物从硫缩脲配合物获得

  摘要：

  Pyridine-2-carbaldehyde thiosemicarbazone 和pyridine-2-carbaldehyde 4N-methyl thiosemicarbazone 配体（分别为 HLI 和 HLImm）在用溴酸盐或碘酸盐处理时发生氧化环化，生成 2-amino-5-pyridin-2-yl-1， 3,4-oxadiazole 和 2-methylamino-5-pyridin-2-yl-1,3,4-oxadiazole (HLII 和 HLIImm)。该反应发生在游离配体或与铜 (II) 配位时。一些起始([{Cu(LImm)(NO3)}2] (3)，中间Cu(LI)(IO3)·(H2O) (1)，[{Cu(LI)I}2] (2) , [{Cu(LImm)Br}2] (4), 和最终化合物 [{Cu(HLII)(H2O)3}2](SO4)2 (5), [{Cu(HLIImm)(H2O)2(

  DOI：

  10.1002/ejic.200200689
• 作为产物：
  描述：

  吡啶-2-甲醛 、 4-甲基氨基硫脲 在 乙醇 作用下， 生成 (E)-N-methyl-2-(pyridin-2-ylmethylene)hydrazinecarbothioamide
  参考文献：
  名称：

  Fujikawa et al., Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1959, vol. 79, p. 1231,1233

  摘要：

  DOI：

文献信息

• Thiosemicarbazones as anti-virals and immunopotentiators
  申请人：Barsanti Paul A.

  公开号：US20090285849A1

  公开（公告）日：2009-11-19

  Novel immune potentiators, novel vaccine adjuvants, novel compounds and pharmaceutical compositions, as well as novel methods for treating viral infections, including HCV, by administering the compounds and compositions, and novel methods for modulating the immune response by administering the compounds and/or compositions.

  新型免疫增强剂、新型疫苗佐剂、新型化合物和制药组合物，以及通过给予这些化合物和组合物治疗病毒感染的新方法，包括HCV，以及通过给予这些化合物和/或组合物调节免疫反应的新方法。
• OPTICAL FILM
  申请人：SK Innovation Co., Ltd.

  公开号：EP2722356A2

  公开（公告）日：2014-04-23

  The present invention relates to a cellulose acetate film for optical compensation and a retardation enhancer used therein, and relates to a cellulose acetate film which has a high retardation value in the thickness direction (Rth).

  本发明涉及一种用于光学补偿的醋酸纤维素薄膜及其所用的缓凝增强剂，并涉及一种在厚度方向上具有高缓凝值（Rth）的醋酸纤维素薄膜。
• Role of Metalation in the Topoisomerase IIα Inhibition and Antiproliferation Activity of a Series of α-Heterocyclic-N⁴-Substituted Thiosemicarbazones and Their Cu(II) Complexes
  作者：Brian M. Zeglis、Vadim Divilov、Jason S. Lewis

  DOI：10.1021/jm101532u

  日期：2011.4.14

  The topoisomerase-Il alpha inhibition and antiproliferative activity of alpha-heterocyclic thiosemicarbazones and their corresponding copper(II) complexes have been investigated. The Cu-II(thiosemicarbazonato)Cl complexes were shown to catalytically inhibit topoisomerase-Il alpha at concentrations (0.3-7.2 mu M) over an order of magnitude lower than their corresponding thiosemicarbazone ligands alone. The copper complexes were also shown to inhibit the proliferation of breast cancer cells expressing high levels of topoisomerase-Il alpha (SK-BR-3) at lower concentrations than cells expressing lower levels of the enzyme (MCF-7).
• Fujikawa et al., Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1959, vol. 79, p. 1231,1233
  作者：Fujikawa et al.

  DOI：——

  日期：——
• Optical Film
  申请人：Kim Won Yeob

  公开号：US20140116293A1

  公开（公告）日：2014-05-01

  The present invention relates to a cellulose acetate film for optical compensation and a retardation enhancer used therein, and relates to a cellulose acetate film which has a high retardation value in the thickness direction (Rth).

表征谱图